Chemoinformaics analysis of ERIODICTYOL-7-O-BETA-D-GLUCOSIDE
| Molecular Weight | 450.396 | nRot | 4 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 24 |
| Exact Molecular Weight | 450.116 | nRing | 4 |
| Solubility: LogS | -3.888 | nHRing | 2 |
| Solubility: LogP | -0.324 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 58.5614 |
| nHD | 7 | BPOL | 28.1466 |
| QED | 0.303 |
| Synth | 4.123 |
| Natural Product Likeliness | 2.197 |
| NR-PPAR-gamma | 0.947 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.292 |
| HIA | 0.855 |
| CACO-2 | -6.485 |
| MDCK | 0.000021 |
| BBB | 0.38 |
| PPB | 0.897802 |
| VDSS | 0.712 |
| FU | 0.130119 |
| CYP1A2-inh | 0.028 |
| CYP1A2-sub | 0.039 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.061 |
| CYP2c9-inh | 0.013 |
| CYP2c9-sub | 0.387 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.217 |
| CYP3a4-inh | 0.075 |
| CYP3a4-sub | 0.081 |
| CL | 9.44 |
| T12 | 0.429 |
| hERG | 0.015 |
| Ames | 0.685 |
| ROA | 0.329 |
| SkinSen | 0.392 |
| Carcinogencity | 0.86 |
| EI | 0.051 |
| Respiratory | 0.068 |
| NR-Aromatase | 0.18 |
| Antiviral | Yes |
| Prediction | 0.731656 |